This may be attributed to the fact that hyperglycemia activates the insulin-like growth factor-1 (IGF-1) and PI3K/AKT/mTOR pro-survival signaling pathways, thereby enhancing the resistance of tumor cells to treatment (35). The gene discussed is MTOR; the disease is Hyperglycemia.